Form 4: Cadre Holdings Director Deborah DeCotis Granted 16,000 Stock Options

Cadre Holdings, Inc. Director Deborah A. DeCotis was granted 16,000 stock options with an exercise price of $32.77, vesting quarterly over the next year.

Summary

• Deborah A. DeCotis, a Director of Cadre Holdings, Inc. (CDRE), was granted 16,000 stock options.
• The transaction date for this grant was May 30, 2025.
• The exercise price for these options is $32.77 per share.
• The options were granted under the Issuer's 2021 Stock Incentive Plan.
• The options have an expiration date of May 30, 2035.
• The options will vest in four equal quarterly tranches of 4,000 shares each, on June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it represents a standard compensation practice that aligns director interests with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of stock options to a director aligns their interests with those of shareholders, incentivizing long-term performance.
• The options are granted under an existing and approved 2021 Stock Incentive Plan, indicating a structured approach to executive and director compensation.

Negatives

• No direct negative information is present in this Form 4 filing, as it reports a standard compensation grant.

Risks

• This Form 4 filing primarily reports an insider transaction and does not detail specific company risks. However, the value of the options is subject to the future performance and stock price of Cadre Holdings, Inc.

Future Outlook

The stock options granted to Director Deborah A. DeCotis are set to vest in four equal quarterly tranches, beginning on June 30, 2025, and concluding on March 31, 2026, indicating a future alignment of interests over this period.

Industry Context

This Form 4 filing reports a routine insider transaction related to director compensation. Stock option grants are a common practice across various industries to incentivize and retain key personnel, aligning their financial interests with the company's long-term performance. This specific grant to a director of Cadre Holdings, a company likely in the safety and survivability products sector, reflects standard corporate governance practices for compensating board members.

Related Party Transactions

• The grant of stock options to Deborah A. DeCotis, a Director of Cadre Holdings, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant of stock options to a director can be viewed positively as it aligns the director's financial interests with the long-term performance of the company, potentially leading to better governance and strategic decisions aimed at increasing shareholder value.

Next Steps

• The stock options will vest in four equal quarterly tranches on June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.

Key Dates

Keywords

Cadre Holdings, CDRE, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, SEC Filing